Peter John Fellner
Director/Board Member chez Ligand UK Development Ltd.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Robert Anthony Kennedy | M | 54 | 13 ans | |
Martin Buckland | M | 69 |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | 13 ans |
Ian Garland | M | 59 |
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a private company that manufactures pharmaceutical products. The company is based in Winnersh, UK.
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 12 ans |
David MacKney | M | 56 |
Ligand UK Development Ltd.
Ligand UK Development Ltd. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Ligand UK Development Ltd. is a private company that manufactures pharmaceutical products. The company is based in Winnersh, UK. | 10 ans |
Michael Wyzga | M | 69 | 5 ans | |
Denise Scots-Knight | M | 64 | 9 ans | |
Keyvan Djamarani | M | 63 | 14 ans | |
Bryan Farrell | M | - | 14 ans | |
Jean-Christophe Tellier | M | 65 | 13 ans | |
Anders Olof Adolf Ekblom | M | 70 | 9 ans | |
Sandford Sommer | M | - | 8 ans | |
Dame Davies | M | 73 | 10 ans | |
Deepa Pakianathan | M | 59 | 5 ans | |
Charles Berkman | M | 55 | 6 ans | |
Jonkheer Cédric van Rijckevorsel | M | 54 | 10 ans | |
Matthew Korenberg | M | 49 | 6 ans | |
Suba Krishnan | M | 59 | 4 ans | |
Christine Fox | F | 43 | 3 ans | |
Xavier Michel | M | - | 11 ans | |
Anne Marie Cairns | F | - | 17 ans | |
Matthew Foehr | M | 51 | 6 ans | |
Justin Roberts | M | - | 2 ans | |
Wills Hughes-Wilson | F | 53 | 6 ans | |
Jeremy Bender | M | 52 | 4 ans | |
Annalisa Jenkins | M | 58 | 2 ans | |
Mike Wood | M | - | 20 ans | |
Pierre Jacquet | M | 57 | 3 ans | |
Iris Löw-Friedrich | M | 63 | 18 ans | |
Michael Watson | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 17 ans |
Cord Dohrmann | M | 60 | 14 ans | |
Marc J. Yoskowitz | M | - | 2 ans | |
Daniel Shames | M | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
William John Jenkins | M | 77 | - | |
Ismail Kola | M | 67 |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | 8 ans |
John A. D. Slater | M | 71 | 10 ans | |
Kristian Rantala | M | 48 | 6 ans | |
Merja Tuulikki Karhapää | F | 62 | - | |
Bo Jesper Hansen | M | 66 | 5 ans | |
Inge Basteleurs | F | - | - | |
Alastair MacKinnon | M | 53 | 7 ans | |
David Mellors | M | 56 | 7 ans | |
Werner Lanthaler | M | 56 | 15 ans | |
David C. Rees | M | - |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | - |
Nick Higgins | M | 67 | 3 ans | |
John McNeil | M | - | - | |
Thomas Taapken | M | 59 | 3 ans | |
David John Cook | M | 57 | 3 ans | |
William Burns | M | 76 | 5 ans | |
Rosalyn Wilton | F | 72 | - | |
Richard Bungay | M | 55 |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | - |
Thomas Leysen | M | 63 | 3 ans | |
Gerhard Mayr | M | 78 | 12 ans | |
Lyn Leaper | M | - |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom.
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | - |
Neil Thompson | M | - |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | - |
Jörn Aldag | M | 65 | 11 ans | |
Thomas Fulton Wilson McKillop | M | 81 | 7 ans | |
John E. Fitzgerald | M | - |
Premier Research Group Ltd.
Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | - |
James Manuso | M | 75 |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | 2 ans |
Nunzio Antonelli | M | - | - | |
Robert Corringham | M | - |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | 1 ans |
Norman J. Ornstein | M | - | - | |
Armand de Decker | M | - | - | |
Stephen Crummett | M | 59 | 8 ans | |
Mark McDade | M | 69 | 8 ans | |
Peter Herbert Kehoe | M | - | - | |
Thomas G. Daniells | M | - | - | |
Alexander Warnock | M | 59 | - | |
Nigel Sheail | M | 59 | - | |
Frank Armstrong | M | 67 | 4 ans | |
Maria Ginman-Horrell | F | 59 | - | |
Lisa Amster Schoenberg | F | 58 | - | |
Andrew Jackson | M | - | 2 ans | |
Jean-Pierre Kinet | M | 70 | - | |
Fabrice Enderlin | M | - | 9 ans | |
Dirk H. Ehlers | M | 63 | 6 ans | |
Lutgart A. A. van den Berghe | M | 72 | - | |
Alison Hood | F | - | - | |
Gordon Davis | M | 67 | 8 ans | |
Walter Wenninger | M | 86 | 6 ans | |
Timothy Haines | M | 67 |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | - |
Hilde Windels | F | 59 | 1 ans | |
David Lawrence | M | 61 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 3 ans |
Noreen Doyle | F | 75 | 9 ans | |
George J. Tenet | M | 71 | 2 ans | |
Stephen Roe | M | - | - | |
John Geoffery Goddard | M | 73 | - | |
Albrecht de Graeve | M | 69 | 14 ans | |
Lynn Drummond | M | 65 | 3 ans | |
David Wilson | M | 61 | - | |
Charmion Gillmore | F | - | - | |
Barry Michael Rose | M | 79 | - | |
Flemming Ørnskov | M | 66 | - | |
Harriet Edelman | F | 68 | 5 ans | |
Carol C. Ferguson | F | 77 | 15 ans | |
Simon Sturge | M | 65 | - | |
Chris Brinsmead | M | 64 | - | |
Adrian Maxwell Colman | M | 54 | 3 ans | |
Klaus Maleck | M | 51 | - | |
Jonathan Glenn | M | 56 | 14 ans | |
Bill Silbey | M | 65 | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Royaume-Uni | 63 | 63,00% |
Belgique | 23 | 23,00% |
Allemagne | 9 | 9,00% |
Etats-Unis | 8 | 8,00% |
Finlande | 6 | 6,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Peter John Fellner
- Réseau Personnel